Obesity Clinical Trial
Official title:
Skeletal Muscle Lipid Metabolism and Insulin Sensitivity: Can Dietary Fatty Acid Composition Modulate Muscle Lipid Storage?
Rationale: The investigators hypothesize that a change in dietary fat quality (an increase
in unsaturated fatty acids) may modulate fuel partitioning within the type 2 diabetic muscle
towards less accumulation of lipid metabolites and an improved insulin sensitivity.
Objective:
1. The contribution of dietary vs endogenous fat sources to lipid overflow in the
circulation and to skeletal muscle lipid uptake and storage in obese insulin resistant
subjects vs obese insulin sensitive controls.
2. The acute effect of meals with various fatty acid composition ((high saturated (SFA) vs
polyunsaturated (PUFA) vs monounsaturated (MUFA)) on skeletal muscle lipid uptake and
storage, fatty acid mediated gene expression and postprandial insulin sensitivity in
obese insulin resistant subjects.
Study design: single-blind randomized cross-over trial
Study population: obese males (35-70 years) with or without insulin resistance
Intervention:
1. 1 test meal
2. 3 test meals with a different fatty acid composition
Main study parameters/endpoints:
More insight whether dietary fat quality may modulate circulating lipids and skeletal muscle
fatty acids handling, and may affect oxidative capacity and lipid storage in parallel to an
increased insulin sensitivity.
| Status | Completed |
| Enrollment | 10 |
| Est. completion date | August 2011 |
| Est. primary completion date | August 2010 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | Male |
| Age group | 35 Years to 70 Years |
| Eligibility |
Inclusion Criteria: - Obese males aged between 35 and 70 years with insulin resistance. Exclusion Criteria: - History of type 2 diabetes. - Liver or kidney failure. - Diseases in which the live expectation is shorter then 5 years. - The use of experimental medication. - Diseases/medication use that may have an influence on the glucose tolerance. - Not to be able to understand the study information. - Users of fatty acid supplements including fish oils etc. - Users of high doses of antioxidant vitamins. - Athletes. - People on a diet of people that are planning to lose weight. |
Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Single Blind (Subject), Primary Purpose: Prevention
| Country | Name | City | State |
|---|---|---|---|
| Netherlands | Maastricht University Medical Centre + | Maastricht | Limburg |
| Lead Sponsor | Collaborator |
|---|---|
| Maastricht University Medical Center |
Netherlands,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Acute effect of meals with various fatty acid composition on postprandial insulin sensitivity | The acute effect of meals with various fatty acid composition ((high saturated (SFA) vs polyunsaturated (PUFA) vs monounsaturated (MUFA)) on postprandial insulin sensitivity will be measured during the stable isotope test. | the individual participants will be measured within 8-10 weeks. | No |
| Primary | Acute effect of meals with various fatty acid composition on forearm muscle fatty acid handling | Using the stable isotope technique, we can differentiate between the metabolic fate of dietary versus endogenous fatty acids | the individual participants will be measured within 8-10 weeks. | No |
| Secondary | Acute effect of meals with various fatty acid composition on intramuscular fatty acid handling | the individual participants will be measured within 8-10 weeks. | No | |
| Secondary | Acute effect of meals with various fatty acid composition on transcriptional regulation of the fatty acid metabolism in skeletal muscle biopsies | Transcriptional regulation will be measured by means of microarray. | the individual participants will be measured within 8-10 weeks. | No |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
| Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
| Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
| Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
| Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
| Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
| Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
| Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
| Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
| Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
| Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
| Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
| Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
| Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
| Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
| Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
| Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
| Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
| Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |